01—Abstract
Summary
Summary of the 8-K filed June 27, 2024. Cited figures are marked; the original filing is the authoritative source.
Insmed Incorporated (Nasdaq: INSM) announced on June 27, 2024 that it has called for redemption all $225 milliona aggregate principal amount of its outstanding 1.75% Convertible Senior Notes due 2025.
The redemption is set for August 9, 2024 (the Redemption Date), at a cash price equal to 100% of principal plus accrued and unpaid interest to, but excluding, that date. The press release states the redemption price is approximately $1,001.17b for each $1,000 principal amount of Notes. Holders may still convert their Notes at any time before 5:00 p.m.
New York City time on August 8, 2024, or later if the Company fails to pay the Redemption Price on the Redemption Date. The Company has elected to settle any conversions in shares of common stock. As of June 27, 2024, the conversion rate is 25.5384 shares per $1,000c principal amount, equivalent to a conversion price of approximately $39.16 per share, and up to 5,746,140 shares would be issued if all Notes are converted.
For investors, the filing is primarily a debt-management event. Settling conversions in stock would introduce up to 5,746,140 new common shares, a potential dilution consideration, while holders who do not convert will receive cash at the redemption price. The filing itself is a notice and does not discuss the company's financial results or the reasons for the redemption beyond the Indenture terms.
02—Key points
Key Highlights
- Insmed called all $225 million of its 1.75% Convertible Senior Notes due 2025 for redemption.
- Redemption date is August 9, 2024, at 100% of principal plus accrued and unpaid interest.
- Redemption price is approximately $1,001.17 per $1,000 principal amount of Notes.
- Holders may convert Notes until 5:00 p.m. New York City time on August 8, 2024.
- Conversion rate is 25.5384 shares per $1,000 principal, about $39.16 per share.
- The Company has elected to settle conversions in shares of common stock.
- Up to 5,746,140 shares of common stock would be issued if all Notes are converted.
03—Questions
Frequently Asked Questions
How much debt is being redeemed?
Insmed has called all $225 million aggregate principal amount of its outstanding 1.75% Convertible Senior Notes due 2025 for redemption.
When will the Notes be redeemed and at what price?
The Notes will be redeemed on August 9, 2024, at a cash price equal to 100% of principal plus accrued and unpaid interest to, but excluding, the Redemption Date. The press release states this is approximately $1,001.17 per $1,000 principal amount.
Can holders still convert their Notes instead of taking the cash redemption?
Yes. Holders may surrender Notes for conversion until 5:00 p.m. New York City time on August 8, 2024, or later if the Redemption Price is not paid on the Redemption Date. The Company will settle conversions in shares of common stock.
What is the conversion price and how many shares could be issued?
As of June 27, 2024, the conversion rate is 25.5384 shares per $1,000 principal amount, equivalent to about $39.16 per share. If all Notes are converted, up to 5,746,140 shares of common stock would be issued.
Does this filing report on Insmed's financial results?
No. The filing is a notice of redemption under Item 8.01 and states it is not itself a notice of redemption or convertibility. It does not discuss operating or financial results.
04—Continue